| Line Item | 2026-01-23 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $790.0M | — | +15.0% |
| Cost of Revenue | $428.0M | — | +46.6% |
| Gross Profit | $362.0M | — | -8.4% |
| R&D Expense | $114.0M | — | +1.8% |
| SG&A Expense | $309.0M | — | +15.3% |
| Operating Income | -$100.0M | — | -576.2% |
| Pre-tax Income | -$99.0M | — | -571.4% |
| Income Tax | $12.0M | — | -57.1% |
| Net Income | -$119.0M | -2280.0% | -1090.0% |
| EPS (Basic) | -$0.47 | — | -1075.0% |
| EPS (Diluted) | -$0.47 | — | -1075.0% |
| Line Item | 2026-01-23 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.0M | — | — |
| Accounts Receivable | $653.0M | — | — |
| Inventory | $408.0M | — | — |
| Current Assets | $1.11B | — | — |
| Total Assets | $4.34B | — | — |
| Current Liabilities | $696.0M | — | — |
| Line Item | 2026-01-23 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$27.0M | — | — |
| Capital Expenditures | $167.0M | — | — |
| Investing Cash Flow | -$177.0M | — | — |
| Financing Cash Flow | $204.0M | — | — |
| Free Cash Flow | -$194.0M | — | — |
| Total Liabilities |
| $881.0M |
| — |
| — |
| Stockholders' Equity | $3.46B | -2.8% | -0.7% |